BDBM50301246 4-guanidino-N-(4-(2-(2-hydroxy-2-(6-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)-2-methylpropyl)phenyl)butanamide::CHEMBL565770

SMILES [#6]C([#6])([#6]-c1ccc(-[#7]-[#6](=O)-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])cc1)[#7]-[#6]-[#6](-[#8])-c1cc(-[#8])cc2-[#7]-[#6](=O)-[#6]-[#8]-c12

InChI Key InChIKey=DWWUCPBOSXEXOB-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50301246   

TargetBeta-2 adrenergic receptor(Human)
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301246(4-guanidino-N-(4-(2-(2-hydroxy-2-(6-hydroxy-3-oxo-...)
Affinity DataEC50:  4.10nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301246(4-guanidino-N-(4-(2-(2-hydroxy-2-(6-hydroxy-3-oxo-...)
Affinity DataEC50:  18nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed